2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Data on Pembro vs. Chemo in MSI-H mCRC: Is There a Clinically Meaningful and Statistically Significant Difference in PFS?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Chloe Atreya
By 2020 ASCO Virtual Direct™ Highlights FEATURING Chloe Atreya
94 views
August 20, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Featured Video

19:51
AstraZeneca Oncology

Management Strategies for Fatigue and Asthenia in First-line Mainten…

Feat. D. Czel, C. Arn
GI
11:26
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced HCC: Is Novel Tremelimumab/Durvalumab R…

Feat. K. Wong
06:33
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Resectable Pancreatic Ductal Adenocarcinoma: Is …

Feat. K. Wong
07:07
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Resectable GE Adenocarcinoma: Does Perioperative…

Feat. K. Wong
06:33
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on HER2+ Esophageal Adenocarcinoma: Does the Additi…

Feat. K. Wong
07:24
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Stage III CRC: Are Patients with Stage III Colon…

Feat. C. Atreya
06:09
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on BRAFV600E mCRC: How Effective Is FDA Approved 2L…

Feat. C. Atreya
10:08
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on HER2+ mCRC: Did Trastuzumab Deruxtecan Demonstra…

Feat. C. Atreya
07:34
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Data on Pembro vs. Chemo in MSI-H mCRC: Is There a Clinica…

Feat. C. Atreya